The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Open accessAbstract
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [5]
In the citing paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
From High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (2020) · cites this paper as [7]
In the citing paper
“The cell surface receptor for the CoV-1 and CoV-2 surface spike protein has been identified by affinity-MS to be angiotensin-converting enzyme 2 (ACE2)147”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [147]
In the citing paper
“As an alternative approach, cellular interaction partners for a single viral protein of interest have also been investigated by in vitro incubation of the viral protein bait with lysates from uninfected permissive cells.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“while promoted upon ACE2 overexpression in HEK293T cells that are otherwise non-permissive to SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“which was further functionally characterized as a functional receptor for SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“MS analysis revealed the cellular metallopeptidase angiotensin-converting enzyme 2 (ACE2) as an S1 interaction partner”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“Viral replication was inhibited upon incubation with antibodies against ACE2”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“This interaction requires cleavage of the S protein, likely by the cell surface protease TMPRSS2, although other proteases (such as Cathepsin B and L, CTSB/CTSL) may also be involved (4-6, 22-25).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“CoV-2 — like SARS-CoV — infects cells through interactions between its spike (S) protein and the ACE2 protein on target cells.”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“ACE2 is the functional entry receptor for both severe acute respiratory syndrome (SARS) coronaviruses, SARS-CoV (36) and SARS-CoV-2 (37).”
From TCRD and pharos 2021: mining the human proteome for disease biology (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N. J., Rollins, B. J., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. J., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,286
Self-citationA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
Cited by
Sorted by citations
Items 301–400 of 1,026
The SARS-CoV S glycoprotein: expression and functional characterization
Xiao, X., Chakraborti, S., Dimitrov, A., Gramatikoff, K., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.054 · Cited by 365
ACE2, a new regulator of the renin–angiotensin system
Burrell, L. M., Johnston, C. I., Tikellis, C., & Cooper, M. E. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.001 · Cited by 365
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 365
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.001 · Cited by 364
“Like SARS-CoV, SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) as an entry receptor binding with nM affinity (Li et al., 2003; Walls et al., 2020; Wrapp et al., 2020; Hoffmann et al., 2020; Letko et al., 2020; Ou et al., 2020).”
Kreutz, R. H., Algharably, E. A. E., Azizi, M., Dobrowolski, P., Guzik, T. J., Januszewicz, A., Persu, A., Prejbisz, A., Riemer, T., Wang, J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa097 · Cited by 366
Ocular Tropism of Respiratory Viruses
Belser, J. A., Rota, P. A., & Tumpey, T. M. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00058-12 · Cited by 361
Wu, K., Li, W., Peng, G., & Li, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908837106 · Cited by 361
Self-citationMolecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 364
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. J. S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 359
Thomas, S., Patel, D. R., Bittel, B. A., Wolski, K., Wang, Q., Kumar, A., Il’Giovine, Z. J., Mehra, R., McWilliams, C. S., Nissen, S. E., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0369 · Cited by 358
The shift to 6G communications: vision and requirements
Akhtar, M. W., Hassan, S. A., Ghaffar, R., Jung, H., Garg, S., & Hossain, M. S. (2020) · Human-centric Computing and Information Sciences · doi:10.1186/s13673-020-00258-2 · Cited by 356
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Ziegler, C. G. K., Miao, V. N., Owings, A. H., Navia, A. W., Tang, Y., Bromley, J. D., Lotfy, P., Sloan, M., Laird, H., Williams, H. B., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.023 · Cited by 358
Bussani, R., Schneider, E., Zentilin, L., Collesi, C., Ali, H., Braga, L., Secco, I., Volpe, M. C., Colliva, A., Zanconati, F., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103104 · Cited by 355
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J. L., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J. E., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01537 · Cited by 357
Going global – Travel and the 2019 novel coronavirus
Rodriguez-Morales, A. J., MacGregor, K., Kanagarajah, S., Patel, D., & Schlagenhauf, P. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101578 · Cited by 353
Zhou, L., Xu, Z., Castiglione, G. M., Soiberman, U., Eberhart, C. G., & Duh, E. J. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.06.007 · Cited by 352
Sims, A. M., Baric, R. S., Yount, B. L., Burkett, S. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15511-15524.2005 · Cited by 350
Gierer, S., Bertram, S., Kaup, F. ‐., Wrensch, F., Heurich, A., Krämer-Kühl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00128-13 · Cited by 346
Coulson, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C. J., Llorens‐Cortés, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 346
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells
Kimura, H., Francisco, D., Conway, M., Martínez, F. D., Vercelli, D., Polverino, F., Billheimer, D. D., & Kraft, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.004 · Cited by 346
Yang, G., Tan, Z., Zhou, L., Yang, M. H., Peng, L., Liu, J., Cai, J., Yang, R., Han, J., Huang, Y., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15143 · Cited by 346
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease
PrabhuDas, M., Baldwin, C. L., Bollyky, P. L., Bowdish, D. M. E., Drickamer, K., Febbraio, M., Herz, J., Kobzik, L., Krieger, M., Loike, J. D., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700373 · Cited by 343
Liang, Y., Wang, M., Chien, C., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y., Lin, Y.-T., Chen, Y.-J., Chang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 347
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S. A., Li, C., Kandimalla, M., Tang, X., Carmona, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 343
COVID-19 and the Chemical Senses: Supporting Players Take Center Stage
Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 341
Glass, W. G., Subbarao, K., Murphy, B. R., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 338
Atri, D. S., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 337
The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in mice
Imai, Y., Kuba, K., & Penninger, J. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040048 · Cited by 337
Bertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirß, K., Nehlmeier, I., Niemeyer, D., He, Y., Simmons, G., Drosten, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05300-11 · Cited by 337
Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 339
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F., Guignabert, C., & Humbert, M. J. C. (2020) · European Respiratory Journal · doi:10.1183/13993003.01634-2020 · Cited by 336
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M. A., Gakhar, L., Chappell, M. C., Wohlford-Lenane, C., & McCray, P. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2009 · Cited by 334
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Sodhi, C. P., Wohlford-Lenane, C., Yamaguchi, Y., Prindle, T., Fulton, W. B., Wang, S., McCray, P. B., Chappell, M. C., Hackam, D. J., & Jia, H. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00498.2016 · Cited by 332
Sex differences in severity and mortality from COVID-19: are males more vulnerable?
Pradhan, A., & Olsson, P. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00330-7 · Cited by 333
Erratum To: Syncytia formation by SARS‐CoV‐2‐infected cells
Buchrieser, J., Dufloo, J., Hubert, M., Monel, B., Planas, D., Rajah, M. M., Planchais, C., Porrot, F., Guivel‐Benhassine, F., van der Werf, S., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020107405 · Cited by 330
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
Jiang, H.-W., Li, Y., Zhang, H.-N., Wang, W., Yang, X., Qi, H., Li, H., Men, D., Zhou, J., & Tao, S.-C. (2020) · Nature Communications · doi:10.1038/s41467-020-17488-8 · Cited by 329
Angiotensin‐converting enzyme 2 in the brain: properties and future directions
Xia, H., & Lazartigues, E. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05723.x · Cited by 323
Insights from nanomedicine into chloroquine efficacy against COVID-19
Hu, Y., Frieman, M. B., & Wolfram, J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0674-9 · Cited by 323
mRNA vaccines for COVID-19: what, why and how
Park, J. W., Lagniton, P. N. P., Liu, Y., & Xu, R.-H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59233 · Cited by 321
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians
Batah, S. S., & Fabro, A. T. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106239 · Cited by 319
Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S.-Q., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 318
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 317
Kuba, K., Zhang, L., Imai, Y., Arab, S., Chen, M., Maekawa, Y., Leschnik, M. W., Leibbrandt, A., Markovic, M., Schwaighofer, J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.158659 · Cited by 316
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M., & Taguchi, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503203102 · Cited by 316
The COVID-19 pandemic face mask waste: A blooming threat to the marine environment
Dharmaraj, S., Ashokkumar, V., Hariharan, S., Manibharathi, A., Show, P. L., Chong, C. T., & Ngamcharussrivichai, C. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.129601 · Cited by 316
Yan, Y., Chang, L., & Wang, L. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2106 · Cited by 315
Alanagreh, L., Alzoughool, F., & Atoum, M. F. M. (2020) · Pathogens · doi:10.3390/pathogens9050331 · Cited by 315
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, P., Barmania, F., Mellet, J., Peta, K. T., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 314
Jaume, M., Yip, M., Cheung, C. Y., Leung, N., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 312
Kruse, R. L. (2020) · F1000Research · doi:10.12688/f1000research.22211.2 · Cited by 312
Fan, H., Wang, L.-Q., Liu, W.-L., An, X.-P., Liu, Z.-D., He, X.-Q., Song, L.-H., & Tong, Y.-G. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000797 · Cited by 311
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
Chhiba, K. D., Patel, G. B., Vu, T. T., Chen, M. M., Guo, A., Kudlaty, E. A., Mai, Q., Yeh, C., Muhammad, L. N., Harris, K. E., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.010 · Cited by 311
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Cuervo, N. Z., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Li, W., Hulswit, R. J. G., Kenney, S. P., Widjaja, I., Jung, K., Alhamo, M. A., van Dieren, B., van Kuppeveld, F. J. M., Saif, L. J., & Bosch, B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802879115 · Cited by 308
Self-citationWang, Y., Liu, M., & Gao, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008209117 · Cited by 307
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
Mittal, A., Manjunath, K., Ranjan, R. K., Kaushik, S., Kumar, S., & Verma, V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008762 · Cited by 304
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target
Abu‐Farha, M., Thanaraj, T. A., Qaddoumi, M. G., Hashem, A. M., Abubaker, J. A., & Al‐Mulla, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103544 · Cited by 303
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., den Berge, K. V., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.25.009084 · Cited by 306
MERS-CoV spike protein: a key target for antivirals
Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F., & Jiang, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1271415 · Cited by 301
Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
Wang, Q., Qi, J., Yuan, Y., Xuan, Y., Han, P., Wan, Y., Ji, W., Li, Y., Wu, Y., Wang, J., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.009 · Cited by 301
Lee, R. A., Herigon, J. C., Benedetti, A., Pollock, N. R., & Denkinger, C. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.02881-20 · Cited by 301
Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)
Leow, M. K., Kwek, D. S., Ng, A. W., Ong, K.-C., Kaw, G. J. L., & Lee, L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02325.x · Cited by 299
Wang, Q., Zhang, L., Kuwahara, K., Li, L., Liu, Z., Li, T., Zhu, H., Liu, J., Xu, Y., Xie, J., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00006 · Cited by 299
Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus
Fehr, A. R., Channappanavar, R., & Perlman, S. M. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051215-031152 · Cited by 299
Leung, J. M., Niikura, M., Yang, C. W. T., & Sin, D. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.02108-2020 · Cited by 297
Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
Kindler, E., Thiel, V., & Weber, F. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.006 · Cited by 296
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 298
Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients
Casagrande, M. K., Fitzek, A., Püschel, K., Aleshcheva, G., Schultheiß, H., Berneking, L., Spitzer, M. S., & Schultheiß, M. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1770301 · Cited by 295
Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1754293 · Cited by 293
Zeng, Q., Langereis, M. A., van Vliet, A. L. W., Huizinga, E. G., & de Groot, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800502105 · Cited by 293
Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
Millet, J. K., & Whittaker, G. R. (2017) · Virology · doi:10.1016/j.virol.2017.12.015 · Cited by 293
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Milewska, A., Zarębski, M., Nowak, P., Stożek, K., Potempa, J., & Pyrć, K. (2014) · Journal of Virology · doi:10.1128/jvi.02078-14 · Cited by 292
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Yang, X., Zhang, Y., Chen, F., Li, D., Deng, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00324-0 · Cited by 292
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Keni, R., Alexander, A., Nayak, P. G., Mudgal, J., & Nandakumar, K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00216 · Cited by 291
Tajbakhsh, A., Hayat, S. M. G., Taghizadeh, H., Akbari, A., inabadi, M., Savardashtaki, A., Johnston, T. P., & Sahebkar, A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822737 · Cited by 290
Lau, S. K. P., Li, K. S. M., Tsang, A. K. L., Lam, C. S. F., Ahmed, S., Chen, H., Chan, K., Woo, P. C. Y., & Yuen, K. (2013) · Journal of Virology · doi:10.1128/jvi.01055-13 · Cited by 289
Risk Factors for Mortality in Patients with COVID-19 in New York City
Mikami, T., Miyashita, H., Yamada, T., Harrington, M. D., Steinberg, D. I., Dunn, A. S., & Siau, E. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05983-z · Cited by 289
Basu, A., Sarkar, A., & Maulik, U. (2020) · Scientific Reports · doi:10.1038/s41598-020-74715-4 · Cited by 289
Moustaqil, M. D., Ollivier, E., Chiu, H.-P., van Tol, S., Rudolffi-Soto, P., Stevens, C. S., Bhumkar, A., Hunter, D. J. B., Freiberg, A. N., Jacques, D. A., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1870414 · Cited by 289
Bats, Civets and the Emergence of SARS
Wang, L. F., & Eaton, B. T. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_13 · Cited by 288
Biological sex impacts COVID-19 outcomes
Klein, S. L., Dhakal, S., Ursin, R. L., Deshpande, S., Sandberg, K. L., & Mauvais‐Jarvis, F. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008570 · Cited by 287
Current status of potential therapeutic candidates for the COVID-19 crisis
Zhang, J., Xie, B., & Hashimoto, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.046 · Cited by 287
Mannose-Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection
Ip, W., Chan, K. H., Law, H., Tso, G. H. W., Kong, E. K., Wong, W. H. S., To, Y. F., Yung, R. W. H., Chow, E. Y., Au, K. L., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429631 · Cited by 284
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters
Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B. R., Zaki, S. R., & Subbarao, K. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.503-511.2005 · Cited by 283
Zhou, N., Pan, T. S., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716100 · Cited by 282
COVID–19-associated coagulopathy: An exploration of mechanisms
Colling, M. E., & Kanthi, Y. M. (2020) · Vascular Medicine · doi:10.1177/1358863x20932640 · Cited by 283
On the origin and evolution of SARS-CoV-2
Singh, D., & Yi, S. V. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00604-z · Cited by 281
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J. A., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 281
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
Amraei, R., & Rahimi, N. (2020) · Cells · doi:10.3390/cells9071652 · Cited by 281
Camargo, S. M. R., Singer, D., Makrides, V., Huggel, K., Pos, K. M., Wagner, C. A., Kuba, K., Danilczyk, U. G., Skovby, F., Kleta, R., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.055 · Cited by 279
Mucosal immune responses to infection and vaccination in the respiratory tract
Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 283
Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I., Choe, H., & Farzan, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4211-4219.2006 · Cited by 278
Self-citationNal, B., Chan, C.-M., Kien, F., Siu, L. Y.-L., Tse, J., Chu, K., Kam, J., Staropoli, I., Crescenzo-Chaigne, B., Escriou, N., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80671-0 · Cited by 278
Griffith, D. M., Sharma, G. V., Holliday, C. S., Enyia, O. K., Valliere, M., Semlow, A. R., Stewart, E. C., & Blumenthal, R. S. (2020) · Preventing Chronic Disease · doi:10.5888/pcd17.200247 · Cited by 276
Rao, S., Lau, A., & So, H. (2020) · Diabetes Care · doi:10.2337/dc20-0643 · Cited by 277
Lipid rafts are involved in SARS-CoV entry into Vero E6 cells
Lu, Y., Liu, D. X., & Tam, J. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.023 · Cited by 271
Shirato, K., & Kizaki, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06187 · Cited by 268
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Nieto-Torres, J. L., DeDiego, M. L., Álvarez, E. A., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Llorente, M., Kremer, L., Shen, S., & Enjuanes, L. (2011) · Virology · doi:10.1016/j.virol.2011.03.029 · Cited by 267
Metadata
- Authors
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Choe, Hyeryun
- Farzan, Michael
- ORCID
- Venue
- Nature
- Published
- 2003-11-27
- Volume
- 426
- Issue
- 6965
- Pages
- 450-454
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095016
- OpenAlex
- W1966238900
- Cited by
- 5,923
- References
- 32
- Citations by year
- 2026: 74 · 2025: 145 · 2024: 298 · 2023: 448 · 2022: 732 · 2021: 1288 · 2020: 1794 · 2019: 32 · 2018: 30 · 2017: 44 · 2016: 50 · 2015: 49 · 2014: 62 · 2013: 43 · 2012: 50
- FWCI
- 79.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Aeronautics and Space Administration
- Hawaii Community Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- angiotensin-converting enzyme 2, SARS coronavirus, viral receptor, receptor binding, syncytium formation, viral replication, ACE1, Vero E6 cells, HEK293T cells, antibody inhibition
- MeSH terms
- Angiotensin-Converting Enzyme 2, Animals, Antibodies, Carboxypeptidases, Cell Line, Chlorocebus aethiops, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Molecular Weight, Protein Binding, Receptors, Virus, Solubility, Transfection, Vero Cells, Viral Envelope Proteins, Virus Replication, Giant Cells, Protein Structure, Tertiary, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
